Genome Canada’s Board of Directors is delighted to welcome two new Board members, Dr. Ingrid Richter and Dr. Avak Kahvejian. Furthermore, Dr. Sohrab Shah has joined as an advisor to the Science and Industry Advisory Committee (SIAC). Each of these esteemed leaders offers valuable expertise and insight, which will be instrumental in furthering our vision, mission, and strategic directions.
Meet Genome Canada’s new Board members:
Dr. Ingrid Richter brings a wealth of experience in leadership and innovation to the Board, serving as Partner at Threshold Associates and Executive-in-Residence at the Telfer School of Management, University of Ottawa. With a focus on strategic change and social innovation, she has contributed to diverse global initiatives, including those for the United Nations and various levels of government in Canada.
Dr. Avak Khavejian is a Partner at Flagship Pioneering and serves as Chairman of the Board of the International Institute of New England. He is a life sciences inventor, entrepreneur and CEO who has co-founded over 10 companies in his career, harnessing a great amount of innovation and commercialization experience.
Meet Genome Canada’s new Science and Industry Advisory Committee member:
Dr. Sohrab Shah is the Chief of Computational Oncology at Memorial Sloan Kettering Cancer Center and a Professor of Physiology, Biophysics and Systems Biology at Weill Cornell Medical College. His research is focused on understanding how tumors evolve over time, bringing innovative oncology expertise to the Committee.
Members of our Board are drawn from across the academic, private and public sectors. Their leadership and vision are vital to our impact as we mobilize the talent and resources of Canada’s genomics ecosystem to improve lives and strengthen communities through applied genomics research and innovation.
SIAC is a permanent committee of our Board that provides advice and recommendations to the Board on emerging scientific opportunity and challenges, international trends, the application of genomics research and more.